SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-23-008695
Filing Date
2023-11-20
Accepted
2023-11-20 16:30:59
Documents
90
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q upxi_10q.htm   iXBRL 10-Q 1086921
2 CERTIFICATION upxi_ex311.htm EX-31.1 10339
3 CERTIFICATION upxi_ex312.htm EX-31.2 12300
4 CERTIFICATION upxi_ex321.htm EX-32.1 3843
5 CERTIFICATION upxi_ex322.htm EX-32.2 3966
  Complete submission text file 0001477932-23-008695.txt   6581311

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA upxi-20230930.xsd EX-101.SCH 80226
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE upxi-20230930_lab.xml EX-101.LAB 405109
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE upxi-20230930_cal.xml EX-101.CAL 66629
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE upxi-20230930_pre.xml EX-101.PRE 364330
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE upxi-20230930_def.xml EX-101.DEF 230754
84 EXTRACTED XBRL INSTANCE DOCUMENT upxi_10q_htm.xml XML 1066757
Mailing Address 3030 ROCKY POINT DRIVE SUITE 420 TAMPA FL 33607
Business Address 3030 ROCKY POINT DRIVE SUITE 420 TAMPA FL 33607 701-353-5425
UPEXI, INC. (Filer) CIK: 0001775194 (see all company filings)

IRS No.: 833378978 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-40535 | Film No.: 231423187
SIC: 2833 Medicinal Chemicals & Botanical Products